Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 8;132(35):12216-7.
doi: 10.1021/ja105772z.

Highly enantioselective catalytic dynamic resolution of N-Boc-2-lithiopiperidine: synthesis of (R)-(+)-N-Boc-pipecolic acid, (S)-(-)-coniine, (S)-(+)-pelletierine, (+)-beta-conhydrine, and (S)-(-)-ropivacaine and formal synthesis of (-)-lasubine II and (+)-cermizine C

Affiliations

Highly enantioselective catalytic dynamic resolution of N-Boc-2-lithiopiperidine: synthesis of (R)-(+)-N-Boc-pipecolic acid, (S)-(-)-coniine, (S)-(+)-pelletierine, (+)-beta-conhydrine, and (S)-(-)-ropivacaine and formal synthesis of (-)-lasubine II and (+)-cermizine C

Timothy K Beng et al. J Am Chem Soc. .

Abstract

The catalytic dynamic resolution (CDR) of rac-2-lithio-N-Boc-piperidine using chiral ligand 8 or its diastereomer 9 in the presence of TMEDA has led to the highly enantioselective syntheses of both enantiomers of 2-substituted piperidines using a wide range of electrophiles. The CDR has been applied to the synthesis of (R)- and (S)-pipecolic acid derivatives, (+)-beta-conhydrine, (S)-(+)-pelletierine, and (S)-(-)-ropivacaine and the formal synthesis of (-)-lasubine II and (+)-cermizine C.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dilithio ligands for dynamic resolution.
Scheme 1
Scheme 1
DTR of N-Boc-2-lithiopiperidine 2.
Scheme 2
Scheme 2
Synthesis of (+)-β-conhydrine i) s-BuLi (1.2 equiv), Et2O, TMEDA (4.0 equiv), –78 °C, 3 h; ii) 8, (10 mol%), –45 °C, 3 h; iii) EtCHO, –78 °C, 2 h; iv) CF3CO2H, CH2Cl2.
Scheme 3
Scheme 3
Synthesis of (S)-(+)-pelletierine and (S)-(−)-coniine. Formal synthesis of (−)-lasubine II and (+)-cermizine C. i) Pd(OH)2 (1.0 eq), H2 (1 atm), MeOH, rt, 48 h; ii) CF3CO2H, CH2Cl2, 0 °C, 2 h, then NaOH, pH 10; iii) PdCl2 (1.0 eq), CuCl (10 mol%), O2, DMF/H2O (10:1), rt, 10 h; iv) CF3CO2H, CH2Cl2, 0 °C, 2 h, then NaOH.
Scheme 4
Scheme 4
Synthesis of (S)-(−)-Ropivacaine i) s-BuLi (1.2 eq), Et2O, TMEDA (4.0 eq), −78 °C, 3 h, then 9, (10 mol%), −45 °C, 3 h, −78 °C, 2,6-dimethylphenyl isocyanate, 2 h, >99:1 er; ii) CF3COOH, CH2Cl2, rt, 10 h, then NaOH; iii) isopropyl alcohol, 1-bromopropane (3.0 equiv), K2CO3 (3.0 equiv), H2O, 100 °C, 6 h.

Similar articles

Cited by

References

    1. Beak P, Lee WK. Tetrahedron Lett. 1989;30:1197.
    1. Kerrick ST, Beak P. J Am Chem Soc. 1991;113:9708.
    1. Bailey WF, Beak P, Kerrick ST, Ma S, Wiberg KB. J Am Chem Soc. 2002;124:1889. - PubMed
    1. Stead D, Carbone G, O’Brien P, Campos KR, Coldham I, Sanderson A. J Am Chem Soc. 2010;132:7260. - PubMed
    1. Coldham I, Raimbault S, Chovatia PT, Patel JJ, Leonori D, Sheikh NS, Whittaker DTE. Chem Commun. 2008:4174. - PubMed

Publication types

MeSH terms